MAPT and Alzheimer disease: To the best of our knowledge, the findings we report here were the first to demonstrate that sulfatide deficiency is sufficient to induce ventricular enlargement, even in the absence of classical AD neuropathological hallmarks, i.e., no amyloid plaques, tau tangles, neuronal death, nor brain shrinkage.